Lluch, Ana; Barríos, Carlos-H; Torrecillas, Laura; Ruiz-Borrego, Manuel; Bines, José; Segalla, José; Guerrero-Zotano, Ángel; García-Saenz, José-A; Torres, Roberto; de-la-Haba, Juan; García-Martínez, Elena; Gómez, Henry-L; Llombart, Antonio; Salvador-Bofill, Javier; Baena-Canada, José-M; Barnadas, Agusti; Calvo, Lourdes; Pérez-Michel, Laura; Ramos, Manuel; Fernández, Isaura; Rodríguez-Lescure, Alvaro; Cardenas, Jesús; Vinholes, Jeferson; Martínez-de-Dueñas, Eduardo; Godes, María-J; Segui, Miguel-A; Anton, Antonio; López-Álvarez, Pilar; Moncayo, Jorge; Amorim, Gilberto; Villar, Esther; Reyes, Salvador; Sampaio, Carlos; Cardemil, Bernardita; Escudero, María-J; Bezares, Susana; Carrasco, Eva; Martín, Miguel; Corona, J; Jara, C; Cardemil, B; Toro, R; Pimentel, C; Hernando, B; Vicente, E; Zagame, L; Gil, M; García-Estevez, L; Rodríguez, C; de-la-Cruz, M-A; Tello, J-M; Campos, S; Lomas, M; Capdevile, D; Campos, M; Margeli, M; Andrés, R; Tusquets, I; Ballesteros, A; Guerrero, A; Arguello, M; Rodríguez, J-L; Muñoz, M; Florian, J; Azevedo, S; Mondragon, R; Peralta, J; Palomo, A-E; Barajas, L-J; Arcusa, A; Carranza, H; García, C; Umbria, C; Ales, José-E; López-Vega, J-M; Romeo, M; Valero, J; Alonso, J-L; Mathias, C; Gutiérrez, F; Adrover, E; Nunez, P; Mendiola, C; Cassinello, J; de-la-Huerta, A
(AMER SOC CLINICAL ONCOLOGY, 2020-01-20)
PURPOSE: Operable triple-negative breast cancers (TNBCs) have a higher risk of relapse than non-TNBCs with standard therapy. The GEICAM/2003-11_CIBOMA/2004-01 trial explored extended adjuvant capecitabine after completion ...